China National Medicines Corp Ltd
SSE:600511

Watchlist Manager

China National Medicines Corp Ltd

SSE:600511

Watchlist

Dividends

Discount Rate

Price: 34.38 CNY -0.12% Market Closed

Market Cap: 25.9B CNY

Have any thoughts about
China National Medicines Corp Ltd?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 34.38 CNY

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

Alert

China National Medicines Corp Ltd

34.38

-0.04 (-0.12%)

52 Week Range	27.4 36.96
Price Target

We'll email you a reminder when the closing price reaches CNY.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

China National Medicines Corp Ltd

What unique competitive advantages
does China National Medicines Corp Ltd hold over its rivals?

What risks and challenges
does China National Medicines Corp Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of China National Medicines Corp Ltd.

What unique competitive advantages
does China National Medicines Corp Ltd hold over its rivals?

What risks and challenges
does China National Medicines Corp Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for China National Medicines Corp Ltd.

Provide P/S
for China National Medicines Corp Ltd.

Provide P/E
for China National Medicines Corp Ltd.

Provide P/OCF
for China National Medicines Corp Ltd.

Provide P/FCFE
for China National Medicines Corp Ltd.

Provide P/B
for China National Medicines Corp Ltd.

Provide EV/S
for China National Medicines Corp Ltd.

Provide EV/GP
for China National Medicines Corp Ltd.

Provide EV/EBITDA
for China National Medicines Corp Ltd.

Provide EV/EBIT
for China National Medicines Corp Ltd.

Provide EV/OCF
for China National Medicines Corp Ltd.

Provide EV/FCFF
for China National Medicines Corp Ltd.

Provide EV/IC
for China National Medicines Corp Ltd.

Show me price targets
for China National Medicines Corp Ltd made by professional analysts.

What are the Revenue projections
for China National Medicines Corp Ltd?

How accurate were the past Revenue estimates
for China National Medicines Corp Ltd?

What are the Net Income projections
for China National Medicines Corp Ltd?

How accurate were the past Net Income estimates
for China National Medicines Corp Ltd?

What are the EPS projections
for China National Medicines Corp Ltd?

How accurate were the past EPS estimates
for China National Medicines Corp Ltd?

What are the EBIT projections
for China National Medicines Corp Ltd?

How accurate were the past EBIT estimates
for China National Medicines Corp Ltd?

Compare the revenue forecasts
for China National Medicines Corp Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of China National Medicines Corp Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of China National Medicines Corp Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of China National Medicines Corp Ltd compared to its peers.

Compare the P/E ratios
of China National Medicines Corp Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing China National Medicines Corp Ltd with its peers.

Analyze the financial leverage
of China National Medicines Corp Ltd compared to its main competitors.

Show all profitability ratios
for China National Medicines Corp Ltd.

Provide ROE
for China National Medicines Corp Ltd.

Provide ROA
for China National Medicines Corp Ltd.

Provide ROIC
for China National Medicines Corp Ltd.

Provide ROCE
for China National Medicines Corp Ltd.

Provide Gross Margin
for China National Medicines Corp Ltd.

Provide Operating Margin
for China National Medicines Corp Ltd.

Provide Net Margin
for China National Medicines Corp Ltd.

Provide FCF Margin
for China National Medicines Corp Ltd.

Show all solvency ratios
for China National Medicines Corp Ltd.

Provide D/E Ratio
for China National Medicines Corp Ltd.

Provide D/A Ratio
for China National Medicines Corp Ltd.

Provide Interest Coverage Ratio
for China National Medicines Corp Ltd.

Provide Altman Z-Score Ratio
for China National Medicines Corp Ltd.

Provide Quick Ratio
for China National Medicines Corp Ltd.

Provide Current Ratio
for China National Medicines Corp Ltd.

Provide Cash Ratio
for China National Medicines Corp Ltd.

What is the historical Revenue growth
over the last 5 years for China National Medicines Corp Ltd?

What is the historical Net Income growth
over the last 5 years for China National Medicines Corp Ltd?

What is the current Free Cash Flow
of China National Medicines Corp Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for China National Medicines Corp Ltd.

China National Medicines Corp Ltd

Balance Sheet

Additional Paid In Capital

China National Medicines Corp Ltd
Additional Paid In Capital

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

China National Medicines Corp Ltd
Additional Paid In Capital Peer Comparison

Comparables:

1099

601607

600998

000963

301015

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company		Additional Paid In Capital	CAGR 3Y	CAGR 5Y	CAGR 10Y
C	China National Medicines Corp Ltd SSE:600511	Additional Paid In Capital ¥2.3B	CAGR 3-Years 0%	CAGR 5-Years 0%	CAGR 10-Years 47%
	Sinopharm Group Co Ltd HKEX:1099	Additional Paid In Capital N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Additional Paid In Capital ¥29.2B	CAGR 3-Years 22%	CAGR 5-Years 13%	CAGR 10-Years 7%
	Jointown Pharmaceutical Group Co Ltd SSE:600998	Additional Paid In Capital ¥5.2B	CAGR 3-Years -14%	CAGR 5-Years -8%	CAGR 10-Years 3%
	Huadong Medicine Co Ltd SZSE:000963	Additional Paid In Capital ¥2.5B	CAGR 3-Years 5%	CAGR 5-Years 3%	CAGR 10-Years 78%
Q	Qingdao Baheal Medical Inc SZSE:301015	Additional Paid In Capital ¥421.7m	CAGR 3-Years 27%	CAGR 5-Years 16%	CAGR 10-Years N/A

What is China National Medicines Corp Ltd's Additional Paid In Capital?

Additional Paid In Capital
2.3B CNY

Based on the financial report for Jun 30, 2024, China National Medicines Corp Ltd's Additional Paid In Capital amounts to 2.3B CNY.

What is China National Medicines Corp Ltd's Additional Paid In Capital growth rate?

Additional Paid In Capital CAGR 10Y
47%

Over the last year, the Additional Paid In Capital growth was 0%.

China National Medicines Corp Ltd
SSE:600511

China National Medicines Corp Ltd
Additional Paid In Capital

China National Medicines Corp Ltd
Additional Paid In Capital Peer Comparison

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

See Also

What is China National Medicines Corp Ltd's Additional Paid In Capital?

Additional Paid In Capital
2.3B CNY

What is China National Medicines Corp Ltd's Additional Paid In Capital growth rate?

Additional Paid In Capital CAGR 10Y
47%

Company

Help

Tools

Stocks

China National Medicines Corp Ltd SSE:600511

China National Medicines Corp Ltd Additional Paid In Capital

China National Medicines Corp Ltd Additional Paid In Capital Peer Comparison

Competitive Additional Paid In Capital Analysis Latest Figures & CAGR of Competitors

See Also

What is China National Medicines Corp Ltd's Additional Paid In Capital? Additional Paid In Capital 2.3B CNY

What is China National Medicines Corp Ltd's Additional Paid In Capital growth rate? Additional Paid In Capital CAGR 10Y 47%

Company

Help

Tools

Stocks

China National Medicines Corp Ltd
SSE:600511

China National Medicines Corp Ltd
Additional Paid In Capital

China National Medicines Corp Ltd
Additional Paid In Capital Peer Comparison

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

What is China National Medicines Corp Ltd's Additional Paid In Capital?

Additional Paid In Capital
2.3B CNY

What is China National Medicines Corp Ltd's Additional Paid In Capital growth rate?

Additional Paid In Capital CAGR 10Y
47%